IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 15 October 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00875-07v1
75/12/5711    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Massey, R. C.
Right arrow Articles by Sewell, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massey, R. C.
Right arrow Articles by Sewell, A. K.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00875-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The use of peptide-MHC tetramer technology to study interactions between S. aureus proteins (TSST-1 and Eap) and human cells

Ruth C. Massey*, Thomas J. Scriba, Eric L. Brown, Rodney E. Phillips, and Andrew K. Sewell

Dept. of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, UK; Nuffield Dept. of Clinical Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, OX1 3SY, UK; University of Texas School of Public Health, 1200 Herman Pressler, Houston, TX 77030, USA; Dept. of Medical Biochemistry and Immunology, Cardiff University School of Medicine, Henry Wellcome Building, Heath Park, Cardiff, CF14 4XN, UK

* To whom correspondence should be addressed. Email: ruth.massey{at}zoo.ox.ac.uk.


   Abstract

In this study we report on the use of peptide major-histocompatability complex (pMHC) tetramer technology to study the interactions that occur between S. aureus proteins and human leukocytes. We demonstrate that this technology can be used to study the activity of superantigens such as TSST-1 and also find that despite similarities with known proteins (i.e. MHCII molecules and superantigens), the S. aureus Eap protein does not block MHC:TCR interactions and is not a superantigen. It has instead a non-specific crosslinking activity that is dependent upon having at least two of its six 110 amino acid repeats.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.